| 논문분류 | 춘계학술대회 초록집 |
|---|---|
| 제목 | 알젠오가노 바이오테크놀로지 |
| 저자 | Yong Kyun Kim |
| 출판정보 | 2022; 2022(1): |
| 키워드 | |
| 초록 | Kidney organoids from human pluripotent stem cells (hPSCs) can provides potentials in the modeling of renal diseases, drug screening, nephrotoxicity test of compounds and regenerative therapy. Rgenorgano Biothechnology is a company for developing new therapy for kidney diseases based on technologies for kidney organoids. In this session, I will introduce Rgenorgano Biothechnology as a R&D company in Nephrology. |
| 원문(PDF) | PDF 원문보기 |